Exp Ther Med. 2018 Oct;16(4):3579-3583. doi: 10.3892/etm.2018.6626. Epub 2018 Aug 20.

Effects of captopril and valsartan on ventricular remodeling and inflammatory cytokines after interventional therapy for AMI.

Experimental and therapeutic medicine

Xiaona Gong, Raorao Zhou, Qinhao Li

PMID: 30233711 PMCID: PMC6143902 DOI: 10.3892/etm.2018.6626

Abstract

The effects of captopril and valsartan on ventricular remodeling and inflammatory cytokines after interventional therapy for acute myocardial infarction (AMI) were investigated. A total of 94 patients with AMI admitted to Honggang Hospital of Dongying from July 2016 to June 2017 were selected as study subjects. The patients were treated with interventional therapy and randomly divided into the observation group (n=47) and the control group (n=47). The control group received aspirin after operation, while the observation group received captopril and valsartan after operation. Three-dimensional ultrasonography was performed to evaluate ventricular remodeling. The related parameters included left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV), left ventricular ejection fraction (LVEF), end-systolic sphericity index/end-diastolic sphericity index (ESSI/EDSI), systolic dyssynchrony index (SDI), diastolic dyssynchrony index (DDI), dispersion end systole (DISPES), DDI-late and DISPED-late. The levels of inflammatory cytokines were determined by enzyme-linked immunosorbent assay (ELISA). The incidence of adverse reactions after treatment was compared. After treatment, LVEF in the control group was significantly lower than that in the observation group, while LVEDV, LVESV and the ratio of early diastolic (E) and late diastolic (A) (E/A) in the control group were significantly higher than those in the observation group (p<0.05). EDSI, DDI-late and DISPED-late in the control group were significantly higher than those in the observation group (p<0.05). ESSI, SDI and DISPES in the control group were significantly higher than those in the observation group (p<0.05). The levels of interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP) and tumor necrosis factor-α (TNF-α) in the observation group were significantly lower than those in the control group at 1, 4 and 8 weeks after treatment (p<0.05). The administration of captopril and valsartan after interventional therapy for AMI can effectively improve the cardiac function of patients, improve the synchronism of left ventricular diastole and contraction, and reduce the level of inflammation. It is safe and reliable, and has important clinical significance.

Keywords: acute myocardial infarction; captopril; inflammatory cytokine; interventional therapy; valsartan; ventricular remodeling

References

1. Am J Med. 2015 Apr;128(4):369-79.e4 - PubMed
2. Coron Artery Dis. 2015 Aug;26(5):402-8 - PubMed
3. J Intern Med Suppl. 1991;734:35-42 - PubMed
4. Br J Clin Pharmacol. 2002 Sep;54(3):327-32 - PubMed
5. J Am Coll Cardiol. 2016 May 3;67(17):2050-60 - PubMed
6. Ren Fail. 2016 Sep;38(8):1167-73 - PubMed
7. Catheter Cardiovasc Interv. 2000 Mar;49(3):237-43 - PubMed
8. Ther Clin Risk Manag. 2016 Jun 24;12:1017-22 - PubMed
9. PLoS One. 2016 Dec 29;11(12):e0168312 - PubMed
10. Eur Heart J. 1998 Sep;19(9):1348-54 - PubMed
11. N Engl J Med. 2015 Sep 10;373(11):1021-31 - PubMed
12. Phytomedicine. 2015 Apr 15;22(4):431-7 - PubMed
13. Inflamm Bowel Dis. 2016 Mar;22(3):560-8 - PubMed
14. Int J Clin Exp Med. 2015 Nov 15;8(11):21089-97 - PubMed
15. CMAJ. 2015 May 19;187(8):E243-52 - PubMed
16. Clin Cardiol. 2015 Jan;38(1):13-9 - PubMed
17. Resuscitation. 2015 Oct;95:264-77 - PubMed
18. Arq Bras Cardiol. 2015 Aug;105(2):145-50 - PubMed
19. Intern Med. 2015;54(18):2299-305 - PubMed
20. J Thorac Dis. 2015 Oct;7(10):1672-5 - PubMed

Publication Types

• Journal Article